| 0 |
DRUG INEFFECTIVE |
7 |
| 1 |
HAEMORRHAGE |
5 |
| 2 |
CONDITION AGGRAVATED |
4 |
| 3 |
DRUG INTOLERANCE |
4 |
| 4 |
INTENTIONAL PRODUCT MISUSE |
4 |
| 5 |
MALAISE |
4 |
| 6 |
OFF LABEL USE |
4 |
| 7 |
RECTAL HAEMORRHAGE |
4 |
| 8 |
ABDOMINAL DISTENSION |
3 |
| 9 |
ANORECTAL DISCOMFORT |
3 |
| 10 |
BLOOD CHOLESTEROL INCREASED |
3 |
| 11 |
BURNING SENSATION |
3 |
| 12 |
CONSTIPATION |
3 |
| 13 |
DIZZINESS |
3 |
| 14 |
DRUG HYPERSENSITIVITY |
3 |
| 15 |
DRY MOUTH |
3 |
| 16 |
DYSPNOEA |
3 |
| 17 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
| 18 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
| 19 |
NAUSEA |
3 |
| 20 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
| 21 |
RASH |
3 |
| 22 |
SOMNOLENCE |
3 |
| 23 |
SWELLING |
3 |
| 24 |
ABDOMINAL DISCOMFORT |
2 |
| 25 |
ABDOMINAL PAIN |
2 |
| 26 |
ANAEMIA |
2 |
| 27 |
ANALGESIC THERAPY |
2 |
| 28 |
APPENDICITIS |
2 |
| 29 |
APPENDICOLITH |
2 |
| 30 |
ASCITES |
2 |
| 31 |
BACTERIAL INFECTION |
2 |
| 32 |
BALANCE DISORDER |
2 |
| 33 |
BLOOD PHOSPHORUS INCREASED |
2 |
| 34 |
BLOOD URIC ACID INCREASED |
2 |
| 35 |
CARDIOGENIC SHOCK |
2 |
| 36 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
| 37 |
COELIAC DISEASE |
2 |
| 38 |
DEATH |
2 |
| 39 |
DIABETES MELLITUS |
2 |
| 40 |
DIARRHOEA |
2 |
| 41 |
DRUG THERAPY |
2 |
| 42 |
DYSPEPSIA |
2 |
| 43 |
HAEMORRHOIDS |
2 |
| 44 |
HEADACHE |
2 |
| 45 |
HYPERPHOSPHATAEMIA |
2 |
| 46 |
HYPERSENSITIVITY |
2 |
| 47 |
HYPONATRAEMIA |
2 |
| 48 |
HYPOPHOSPHATAEMIA |
2 |
| 49 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
| 50 |
INFLAMMATION |
2 |
| 51 |
IRON DEFICIENCY |
2 |
| 52 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
| 53 |
MYASTHENIA GRAVIS |
2 |
| 54 |
NEURALGIA |
2 |
| 55 |
PAIN |
2 |
| 56 |
PRODUCT USE COMPLAINT |
2 |
| 57 |
PRURITUS |
2 |
| 58 |
PULMONARY EMBOLISM |
2 |
| 59 |
SEPSIS |
2 |
| 60 |
SLEEP DISORDER THERAPY |
2 |
| 61 |
STRESS |
2 |
| 62 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
| 63 |
THROMBOSIS |
2 |
| 64 |
URTICARIA |
2 |
| 65 |
VENTRICULAR FIBRILLATION |
2 |
| 66 |
VOMITING |
2 |
| 67 |
ABNORMAL BEHAVIOUR |
1 |
| 68 |
ADVERSE REACTION |
1 |
| 69 |
ALOPECIA |
1 |
| 70 |
ANAL HAEMORRHAGE |
1 |
| 71 |
ANAL INFLAMMATION |
1 |
| 72 |
ANAL PRURITUS |
1 |
| 73 |
ANIMAL BITE |
1 |
| 74 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
| 75 |
ANXIETY |
1 |
| 76 |
ARTHRALGIA |
1 |
| 77 |
ARTHROPATHY |
1 |
| 78 |
BACK PAIN |
1 |
| 79 |
BLADDER PAIN |
1 |
| 80 |
BLISTER |
1 |
| 81 |
BURSITIS |
1 |
| 82 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
| 83 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 84 |
CATHETER SITE DISCHARGE |
1 |
| 85 |
CATHETER SITE INFECTION |
1 |
| 86 |
CELLULITIS |
1 |
| 87 |
CEREBROVASCULAR ACCIDENT |
1 |
| 88 |
CHEST DISCOMFORT |
1 |
| 89 |
CONFUSIONAL STATE |
1 |
| 90 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
| 91 |
COUGH |
1 |
| 92 |
CRYING |
1 |
| 93 |
DECREASED APPETITE |
1 |
| 94 |
DISCOMFORT |
1 |
| 95 |
DRUG-INDUCED LIVER INJURY |
1 |
| 96 |
ERYTHEMA |
1 |
| 97 |
EXPIRED PRODUCT ADMINISTERED |
1 |
| 98 |
EXPOSURE DURING PREGNANCY |
1 |
| 99 |
EYE IRRITATION |
1 |
| 100 |
FATIGUE |
1 |
| 101 |
FEELING HOT |
1 |
| 102 |
FOLLICULITIS |
1 |
| 103 |
FUNGAL INFECTION |
1 |
| 104 |
GASTROINTESTINAL DISORDER |
1 |
| 105 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
| 106 |
GLOSSODYNIA |
1 |
| 107 |
GRIP STRENGTH DECREASED |
1 |
| 108 |
HAND DEFORMITY |
1 |
| 109 |
HEPATIC ENZYME INCREASED |
1 |
| 110 |
HYPERTENSION |
1 |
| 111 |
HYPOAESTHESIA |
1 |
| 112 |
ILL-DEFINED DISORDER |
1 |
| 113 |
INFUSION RELATED REACTION |
1 |
| 114 |
INFUSION SITE ERYTHEMA |
1 |
| 115 |
INFUSION SITE PAIN |
1 |
| 116 |
INFUSION SITE SWELLING |
1 |
| 117 |
INFUSION SITE WARMTH |
1 |
| 118 |
INJECTION SITE INFECTION |
1 |
| 119 |
INJECTION SITE IRRITATION |
1 |
| 120 |
INJECTION SITE MASS |
1 |
| 121 |
INJECTION SITE PAIN |
1 |
| 122 |
INJECTION SITE REACTION |
1 |
| 123 |
INSOMNIA |
1 |
| 124 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
| 125 |
IRREGULAR SLEEP WAKE RHYTHM DISORDER |
1 |
| 126 |
IRRITABLE BOWEL SYNDROME |
1 |
| 127 |
JOINT SWELLING |
1 |
| 128 |
LACRIMATION INCREASED |
1 |
| 129 |
LIVE BIRTH |
1 |
| 130 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 131 |
MOBILITY DECREASED |
1 |
| 132 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 133 |
NAIL DISORDER |
1 |
| 134 |
NEOPLASM MALIGNANT |
1 |
| 135 |
ONYCHOMADESIS |
1 |
| 136 |
ONYCHOMYCOSIS |
1 |
| 137 |
ORAL PAIN |
1 |
| 138 |
PALPITATIONS |
1 |
| 139 |
PARAESTHESIA |
1 |
| 140 |
PEMPHIGUS |
1 |
| 141 |
PERICARDITIS |
1 |
| 142 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
| 143 |
PROCTALGIA |
1 |
| 144 |
PRODUCT COLOUR ISSUE |
1 |
| 145 |
PRODUCT DOSE OMISSION ISSUE |
1 |
| 146 |
PRODUCT LABEL CONFUSION |
1 |
| 147 |
PRODUCT PHYSICAL ISSUE |
1 |
| 148 |
PRODUCT SIZE ISSUE |
1 |
| 149 |
PRODUCT USE ISSUE |
1 |
| 150 |
PROSTATIC PAIN |
1 |
| 151 |
PSORIATIC ARTHROPATHY |
1 |
| 152 |
RHEUMATIC FEVER |
1 |
| 153 |
RHEUMATOID ARTHRITIS |
1 |
| 154 |
RUBELLA |
1 |
| 155 |
SKIN IRRITATION |
1 |
| 156 |
SLEEP DISORDER |
1 |
| 157 |
SYNCOPE |
1 |
| 158 |
SYNOVITIS |
1 |
| 159 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 160 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
| 161 |
TOOTH INFECTION |
1 |
| 162 |
TREATMENT FAILURE |
1 |
| 163 |
TREMOR |
1 |
| 164 |
TYPE 2 DIABETES MELLITUS |
1 |
| 165 |
URINARY TRACT INFECTION |
1 |
| 166 |
URINE FLOW DECREASED |
1 |
| 167 |
VERTIGO |
1 |
| 168 |
WOUND |
1 |
| 169 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |